Pub. Date : 2021 Jul 15
PMID : 32668455
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | We evaluated whether people receiving dolutegravir (DTG) plus F/TAF or F/tenofovir disoproxil fumarate (TDF) with viral suppression can switch to B/F/TAF without compromising safety or efficacy, regardless of pre-existing NRTI resistance. | dolutegravir | TATA-box binding protein associated factor 8 | Homo sapiens |
| 2 | INTERPRETATION: The single-tablet regimen B/F/TAF is a safe, effective option for people virologically suppressed on DTG plus either F/TDF or F/TAF, including in individuals with pre-existing resistance to NRTIs. | dolutegravir | TATA-box binding protein associated factor 8 | Homo sapiens |